ICBioMed 2022– Current Options for the Treatment of Advanced or Metastatic NSCLC

ICBioMed 2023-ER stress and UPR in the cancer cellsПодробнее

ICBioMed 2022– Advanced Design of Next-Generation Glucose BiosensorsПодробнее

Treatment for Patients with Advanced NSCLC - Leading Developments & Current Questions in Lung CancerПодробнее

Oncogene-Driven Metastatic NSCLC: Frontline Treatment & Resistance Mechanisms - OncTalk 2022Подробнее

ICBioMed 2022– Systems Analysis of Aggressive Cancer Spread, by Prof. Andre LevchenkoПодробнее

Molecular Biomarker Revolution in Metastatic NSCLCПодробнее

ICBioMed 2022– The Current Status of Finite Element Analysis in the Application of...Подробнее

Metastatic Lung Cancer | 2022 OneOncology ConferenceПодробнее

Recent Advances in Lung CancerПодробнее

ICBioMed 2021 – Predicting Response to Cancer TreatmentПодробнее

ICBioMed 2023-Quantitative and Predictive Analysis of Therapeutic WindowsПодробнее

ICBioMed 2022– Exploring the Mechanism of Action of Three Agents White Powder in the Care for...Подробнее

Treatment After Progression in Advanced-Stage NSCLCПодробнее

ICBioMed 2023-Research on the neural circuits and treatment of anxietyПодробнее

ICBioMed 2022– Coronary Intravascular Imaging and Physiological Function for Optimization of...Подробнее

ICBioMed 2023-Phenylketonuria (PKU): Causes, Classifications, Clinical Symptoms, Diagnosis and Tre..Подробнее

Treating Limited and Advanced Stage SCLC - 2022 Program: LCVLПодробнее